Health Care Roundup: Market Talk

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.

0029 GMT – Malaysian glove maker Kossan’s 4Q performance is likely to be flattish on year, says CIMB Securities, expecting the industry’s operating landscape to remain challenging in the long term due to demand-supply imbalances. The commissioning of new overseas glove manufacturing plants in Indonesia by Chinese manufacturers in 4Q may also pose a threat to Malaysian glove exports to the U.S., says analyst Chun Sung Oong in a note. Oong cuts core net profit forecasts for 2025-2027 by 15%, 20%, and 7%, respectively, after factoring in lower average selling prices, lower sales volumes and a stronger ringgit. CIMB downgrades the stock to hold and cuts the target price to MYR1.15 to reflect the absence of near-term re-rating catalysts and heightened competition. (monica.gupta@wsj.com)